Migrating Minds

When Sandra Panchalingam finished her PhD studies at the University of Birmingham, she set her sights on the United States. "I knew that no matter how hard I worked in the United Kingdom, I would probably never get a chance to run my own lab," she says. "I always believed that in America, if you worked hard, there was an opportunity to reap the benefits. That's not always true in Europe." Now her postdoctoral training at the University of Maryland is winding down and Panchalingam is completing

Written bySam Jaffe
| 9 min read

Register for free to listen to this article
Listen with Speechify
0:00
9:00
Share

Now her postdoctoral training at the University of Maryland is winding down and Panchalingam is completing work under a US Department of Defense grant for breast-cancer research. So she is looking for a job. But she won't look in Europe. "It's a very closed system there," she says. "I have a lot of friends in the United Kingdom, but I might end up being a postdoc for 15 years. It's just not worth it."

Panchalingam is exactly the type of person Europe wants to return to its shores. Since the end of World War II, the best and brightest British, French, and German graduate students have traditionally finished their studies in the United States and often remained, the trend reversed for a brief period in the late 1960s and early 1970s when many US researchers headed to Britain. Nevertheless, today, Greeks, Spaniards, and Eastern Europeans join the British in the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies